首页> 外文期刊>Hepato-gastroenterology. >Low- and high-grade non-invasive gastric neoplasia (formerly dysplasia): cytological differentiation (gastro-entero-pancreatic antigens) in association with p53 pattern expression.
【24h】

Low- and high-grade non-invasive gastric neoplasia (formerly dysplasia): cytological differentiation (gastro-entero-pancreatic antigens) in association with p53 pattern expression.

机译:低度和高度非侵入性胃肿瘤(以前为发育异常):细胞学分化(胃-肠-胰腺抗原)与p53模式表达相关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: In order to better define the evolutive potentiality of non-invasive neoplasia (formerly dysplasia) a study of the cytological differentiation and of the behavior of p53 in relation to the clinical progress has been performed. METHODOLOGY: Gastro-entero-pancreatic antigens, p53 and Ki-67 expression were evaluated in 120 cases of epithelial gastric dysplasia: 70 cases of low-grade dysplasia (LGD) and 50 cases of high-grade dysplasia (HGD). For the cytological study four antigens were studied: two of them gastric (pepsinogen C, gastric foveolar M1), one enteric (CAR-5) and one pancreatic (DU-PAN-2). Routinely processed tissue sections of a colon carcinoma known to contain mutant p53 were used as positive controls for p53 immunohistochemistry. For Ki-67 immunohistochemistry, routinely processed tissue sections of normal lymph node and tonsil were used as staining controls. RESULTS: The study of the coexpression of the gastro-entero-pancreatic antigens showed how all cases of non-invasive neoplasia associated with or progressed to gastric carcinoma (GC) were characterized by entero-pancreatic markers and, in particular, in case of LGD p53 expression positivity was evidenced in 66.6% of cases. Ki-67 hyperproliferation is present in 100% of cases. CONCLUSIONS: The cytological study, only if confirmed by wider casuistries, could represent further information in order to better define the follow-up and the therapeutical decisions in case of non-invasive gastric neoplasia therefore, the immunophenotypic study in association with p53 could lead to more personalized therapeutical choices.
机译:背景/目的:为了更好地定义非侵入性瘤形成(以前的发育不良)的发展潜力,已经进行了关于细胞分化和p53的行为与临床进展相关的研究。方法:在120例上皮性胃异型增生:70例低度异型增生(LGD)和50例高度异型增生(HGD)中评估了胃肠道-胰腺抗原,p53和Ki-67的表达。为了进行细胞学研究,研究了四种抗原:其中两种为胃(胃蛋白酶原C,胃小叶M1),一种为肠溶性(CAR-5)和一种为胰腺(DU-PAN-2)。将已知含有突变型p53的结肠癌的常规加工组织切片用作p53免疫组织化学的阳性对照。对于Ki-67免疫组织化学,正常淋巴结和扁桃体的常规处理组织切片用作染色对照。结果:对胃肠道-胰腺抗原共表达的研究表明,与肠癌(GC)有关或进展为胃癌(GC)的所有非侵袭性赘生病例如何以肠-胰腺标志物为特征,特别是在LGD的情况下在66.6%的病例中证实了p53表达阳性。 Ki-67过度增殖存在于100%的病例中。结论:细胞学研究只有得到更广泛的研究机构的确认,才能代表更多信息,以便更好地确定无创性胃肿瘤的随访和治疗决策,因此,与p53相关的免疫表型研究可能导致更多个性化的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号